These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 8979664
41. Rifabutin prophylaxis against Mycobacterium avium complex infections in HIV-infected patients: impact on the incidence of campylobacteriosis. Pulik M, Genet P, Leturdu F, Lionnet F, Louvel D, Touahri T. AIDS Patient Care STDS; 1999 Aug; 13(8):467-72. PubMed ID: 10800525 [Abstract] [Full Text] [Related]
42. [Rifabutin-associated hypopyon uveitis in patient with acquired immunodeficiency syndrome]. Ishiguchi N, Ueno K, Yanagihara M, Kadono K, Oshika T. Nippon Ganka Gakkai Zasshi; 2010 Aug; 114(8):683-6. PubMed ID: 20803988 [Abstract] [Full Text] [Related]
43. [Rifabutin-associated with bilateral uveitis in an HIV negative patient]. Müller K, Grieshaber MC, Orgül S. Klin Monbl Augenheilkd; 2008 May; 225(5):448-50. PubMed ID: 18454395 [Abstract] [Full Text] [Related]
44. [Current status in the prevention of Mycobacterium avium complex infections in patients with HIV infection]. Doco-Lecompte T, Brel F, May T, Perronne C. Ann Med Interne (Paris); 1997 May; 148(2):167-71. PubMed ID: 9238443 [Abstract] [Full Text] [Related]
52. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients]. Shirasaka T. Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110 [Abstract] [Full Text] [Related]
53. Rifabutin-associated uveitis during prophylaxis for Mycobacterium avium complex infection. Rifai A, Peyman GA, Daun M, Wafapoor H. Arch Ophthalmol; 1995 Jun; 113(6):707. PubMed ID: 7786206 [No Abstract] [Full Text] [Related]
54. [Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. Clinical Epidemiology Group of the Information and Care Center for Human Immunodeficiency]. Mary-Krause M, Rabaud C, Jouan M, Obadia M, de la Blanchardière A, Raffi F, May T. Pathol Biol (Paris); 2000 Jun; 48(5):495-504. PubMed ID: 10949848 [Abstract] [Full Text] [Related]
55. [Rifabutin. An antibiotic against mycobacteria]. Andersen AB. Ugeskr Laeger; 1997 Nov 10; 159(46):6844-8. PubMed ID: 9412003 [No Abstract] [Full Text] [Related]
56. Idiosyncratic rifabutin-induced leukopenia and SIADH: case report and review. Chitre MM, Berenson CS. Pharmacotherapy; 2001 Apr 10; 21(4):493-7. PubMed ID: 11310523 [Abstract] [Full Text] [Related]
57. Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran. Tabarsi P, Baghaei P, Mirsaeidi M, Amiri M, Alipanah N, Emami H, Novin A, Mansouri D, Masjedi MR, Velayati AA. Saudi Med J; 2008 Jan 10; 29(1):148-50. PubMed ID: 18176695 [No Abstract] [Full Text] [Related]
58. Prophylactic antibiotic receives speedy FDA approval to reduce MAC disease in advanced HIV. AIDS Patient Care STDS; 1996 Dec 10; 10(6):379. PubMed ID: 11361569 [No Abstract] [Full Text] [Related]